These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26486517)

  • 21. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
    Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study.
    Pérol M; Léna H; Thomas P; Robinet G; Fournel P; Coste E; Belleguic C; Le Caer H; Blanchon F; Vergnenègre A; Vernejoux JM; Schuller-Lebeau MP; Pham E
    Ann Oncol; 2002 May; 13(5):742-7. PubMed ID: 12075743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines.
    Martí JL; Bueso P; Mayordomo JI; Isla MD; Saenz A; Escudero P; Murillo L; Filipovich E; Andres R; Tres A
    Ann Oncol; 2001 Aug; 12(8):1061-5. PubMed ID: 11583186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study.
    Esteban E; Modollel A; González de Sande L; Palacio I; Muñiz I; Fernández Y; Corral N; Fra J; Sala M; Vieitez JM; Estrada E; Lacave AJ;
    Breast Cancer Res Treat; 2003 Aug; 80(3):257-65. PubMed ID: 14503798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.
    Ibrahim NK; Rahman Z; Valero V; Murray JL; Frye D; Hortobagyi GN
    Cancer Invest; 2002; 20(1):29-37. PubMed ID: 11852999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.
    Aravantinos G; Bafaloukos D; Fountzilas G; Christodoulou C; Papadimitriou C; Pavlidis N; Kalofonos HP; Gogas H; Kosmidis P; Dimopoulos MA
    Ann Oncol; 2003 Jul; 14(7):1094-9. PubMed ID: 12853352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.
    Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP
    Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
    Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
    Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
    Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
    Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.
    Miller VA; Ng KK; Krug LM; Perez W; Pizzo B; Heelan RT; Kris MG
    Cancer; 2000 Mar; 88(5):1045-50. PubMed ID: 10699893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4.
    Bash-Babula J; Toppmeyer D; Labassi M; Reidy J; Orlick M; Senzon R; Alli E; Kearney T; August D; Shih W; Yang JM; Hait WN
    Clin Cancer Res; 2002 May; 8(5):1057-64. PubMed ID: 12006519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor.
    Yang SH; Lin CC; Lin ZZ; Tseng YL; Hong RL
    Invest New Drugs; 2012 Feb; 30(1):282-9. PubMed ID: 20809205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.
    Saeki T; Takashima S; Ogita M; Tabei T; Adachi I; Tamura K; Takatsuka Y; Kanda K
    Breast Cancer; 2006; 13(2):159-65. PubMed ID: 16755111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weekly vinorelbine and docetaxel as second-line chemotherapy for pretreated non-small cell lung cancer patients: a phase I-II trial.
    Nelli F; Naso G; De Pasquale Ceratti A; Saltarelli R; Dauria G; Lugini A; Ferraldeschi R; Picone V; Moscetti L; Cortesi E
    J Chemother; 2004 Aug; 16(4):392-9. PubMed ID: 15332716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docetaxel combined with vinorelbine: phase I results and new study designs.
    Fumoleau P; Féty R; Delecroix V; Perrocheau G; Azli N
    Oncology (Williston Park); 1997 Jun; 11(6 Suppl 6):29-31. PubMed ID: 9213325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors.
    Peacock NW; Burris HA; Dieras V; Smith L; Rodriguez GI; Eckardt JR; Jones SF; Hardy J; Hohneker J; Bigley J; Von Hoff DD
    Invest New Drugs; 1998; 16(1):37-43. PubMed ID: 9740542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I study of Doxil and vinorelbine in metastatic breast cancer.
    Burstein HJ; Ramirez MJ; Petros WP; Clarke KD; Warmuth MA; Marcom PK; Matulonis UA; Parker LM; Harris LN; Winer EP
    Ann Oncol; 1999 Sep; 10(9):1113-6. PubMed ID: 10572612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinoma.
    Pawlicki M; Rolski J; Zaluski J; Siedlecki P; Ramlau C; Tomzak P
    Oncologist; 2002; 7(3):205-9. PubMed ID: 12065792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.